Previous immunohistochemical studies have demonstrated that CD44 expression in RCC was notably elevated, and augmented expression of CD44 and MMP-9 was positively associated with metastatic ccRCC [17,18]. This evidence concerns the gene CD44 and renal cell carcinoma.